Regeneron Pharmaceuticals, Inc.
Mitochondrial DNA Quality Control
Last updated:
Abstract:
The present disclosure provides methods of identifying unreliable biological samples that may be mislabeled or contaminated, by determining the heteroplasmy and homoplasmy of mitochondrial DNA present in the biological samples.
Status:
Application
Type:
Utility
Filling date:
6 Aug 2021
Issue date:
10 Feb 2022